Type I IFN-mediated NET release promotes Mycobacterium tuberculosis replication and is associated with granuloma

Chanchal Sur Chowdhury1, Rachel L Kinsella1, Michael E McNehlan1

  • 1Department of Molecular Microbiology, Center for Women's Infectious Disease Research, Washington University School of Medicine, St. Louis, MO 63110, USA.

Cell Host & Microbe
|December 5, 2024
PubMed

Insights

Neutrophil extracellular traps (NETs) promote Mycobacterium tuberculosis (Mtb) replication by releasing citrullinated histones. Type I interferon facilitates NET release, offering a potential target to inhibit Mtb pathogenesis.

Area of Science:

  • Immunology
  • Microbiology
  • Cell Biology

Background:

  • Neutrophils are abundant in tuberculosis airways.
  • Mycobacterium tuberculosis (Mtb) infection triggers neutrophil extracellular trap (NET) release.
  • The regulation and impact of NETs in Mtb pathogenesis are not well understood.

Purpose of the Study:

  • To investigate the molecular mechanisms regulating NET release during Mtb infection.
  • To determine the role of NETs in Mtb pathogenesis.
  • To identify potential therapeutic targets for tuberculosis.

Main Methods:

  • Studied histone citrullination by PAD4 in neutrophils during Mtb infection.
  • Investigated the role of type I interferon in NET formation and release.
  • Analyzed NETs in nonhuman primate granulomas.

Main Results:

  • PAD4-mediated histone citrullination enables NET release, maintaining neutrophil viability and promoting Mtb replication.
  • Type I interferon induces vesicle formation for NET release, preserving plasma membrane integrity.
  • NETs are associated with necrosis and caseation in nonhuman primate granulomas.

Conclusions:

  • NET release is a key mechanism in Mtb pathogenesis, regulated by PAD4 and type I interferon.
  • Targeting NET release presents a promising strategy for inhibiting Mtb.
  • Understanding NET regulation can lead to novel tuberculosis therapies.

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
211
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
303
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
133
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.2K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
846